Expression profile of EPHB3 and its prognostic significance in colorectal cancer progression (Running head: Prognostic value of EPHB3 in colorectal cancers)

被引：0
|
作者：
Jang, B. [1 ]
Kim, H. [1 ]
机构：
[1] Jeju Natl Univ, Sch Med, Pathol, Jeju Si, South Korea
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
640P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The expression profile of EPHB3 during colorectal cancer progression and the prognostic impact of EPHB3 in colorectal cancer patients
    Song, S.
    Hyun, C.
    VIRCHOWS ARCHIV, 2019, 475 : S202 - S202
  • [2] Expression Profile and Prognostic Significance of EPHB3 in Colorectal Cancer
    Jang, Bo Gun
    Kim, Hye Sung
    Bae, Jeong Mo
    Kim, Woo Ho
    Hyun, Chang Lim
    Kang, Gyeong Hoon
    BIOMOLECULES, 2020, 10 (04)
  • [3] Receptor Tyrosine Kinase EphB3: a Prognostic Indicator in Colorectal Carcinoma
    Xuan, Zhuoqi
    Huang, Jianming
    Gao, Lin
    Wang, Yong
    Wang, Jiandong
    Sun, Yueming
    PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (01) : 541 - 549
  • [4] Prognostic and Clinicopathological Significance of EphB3 and Dysadherin Expression in Extrahepatic Cholangiocarcinoma
    Wu, Zhengchun
    Liu, Rushi
    Xiong, Li
    Miao, Xiongying
    Li, Daiqiang
    Zou, Qiong
    Yuan, Yuan
    Yang, Zhulin
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 221 - 232
  • [5] EphB3 and EphB4 receptor expression in prostate cancer - a future diagnostic and prognostic marker?
    Wall, J. W.
    Stonier, T. S.
    Nobes, C. D. N.
    BRITISH JOURNAL OF SURGERY, 2012, 99 : 58 - 58
  • [6] Prognostic Significance of EPHB2 Expression in Colorectal Cancer Progression
    Jang, Bo Gun
    Kim, Hye Sung
    Chang, Weon Young
    Bae, Jeong Mo
    Kang, Gyeong Hoon
    JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2018, 52 (05) : 298 - 306
  • [7] Circ_0000518 regulates miR-326/EPHB3 axis to promote colorectal cancer progression
    Pang, Qiang
    Cao, Jiaqing
    GENE REPORTS, 2024, 36
  • [8] Sonic hedgehog pathway activation is associated with cetuximab resistance and EPHB3 receptor induction in colorectal cancer
    Park, Seong Hye
    Jo, Min Jee
    Kim, Bo Ram
    Jeong, Yoon A.
    Na, Yoo Jin
    Kim, Jung Lim
    Jeong, Soyeon
    Yun, Hye Kyeong
    Kim, Dae Yeong
    Kim, Bu Gyeom
    Kang, Sang Hee
    Oh, Sang Cheul
    Lee, Dae-Hee
    THERANOSTICS, 2019, 9 (08): : 2235 - 2251
  • [9] Low Expression of EphB2, EphB3, and EphB4 in Bladder Cancer: Novel Potential Indicators of Muscular Invasion
    Lee, Tae Ho
    Heo, Jin Hyung
    Jeong, Ju-Yeon
    Lee, Gee Hoon
    Park, Dong Soo
    Kim, Tae Hoen
    YONSEI MEDICAL JOURNAL, 2021, 62 (08) : 679 - 690
  • [10] Silencing of the EPHB3 tumor-suppressor gene in human colorectal cancer through decommissioning of a transcriptional enhancer
    Jaegle, Sabine
    Roensch, Kerstin
    Timme, Sylvia
    Andrlova, Hana
    Bertrand, Miriam
    Jaeger, Marcel
    Proske, Amelie
    Schrempp, Monika
    Yousaf, Afsheen
    Michoel, Tom
    Zeiser, Robert
    Werner, Martin
    Lassmann, Silke
    Hecht, Andreas
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (13) : 4886 - 4891
12345